Lawrence S. Young

Active 1972–2025

175
Papers
33,473
Citations
109
h-index
172
i10-index

Citations

Citations per year for Lawrence S. Young1972: 2 citations1973: 3 citations1974: 4 citations1975: 3 citations1976: 3 citations1977: 8 citations1978: 7 citations1979: 13 citations1980: 12 citations1981: 8 citations1982: 10 citations1983: 22 citations1984: 24 citations1985: 13 citations1986: 5 citations1987: 33 citations1988: 49 citations1989: 81 citations1990: 107 citations1991: 190 citations1992: 227 citations1993: 295 citations1994: 176 citations1995: 222 citations1996: 216 citations1997: 214 citations1998: 158 citations1999: 273 citations2000: 316 citations2001: 286 citations2002: 232 citations2003: 259 citations2004: 212 citations2005: 186 citations2006: 247 citations2007: 249 citations2008: 239 citations2009: 217 citations2010: 193 citations2011: 181 citations2012: 189 citations2013: 161 citations2014: 197 citations2015: 196 citations2016: 142 citations2017: 122 citations2018: 153 citations2019: 448 citations2020: 420 citations2021: 558 citations2022: 402 citations2023: 311 citations2024: 468 citations2025: 200 citations2026: 5 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,322 citing papers, 28.9% of this breakdownChina: 869 citing papers, 10.8% of this breakdownUnited Kingdom: 749 citing papers, 9.3% of this breakdownGermany: 438 citing papers, 5.4% of this breakdownJapan: 289 citing papers, 3.6% of this breakdownFrance: 278 citing papers, 3.5% of this breakdownItaly: 255 citing papers, 3.2% of this breakdownCanada: 214 citing papers, 2.7% of this breakdownNetherlands: 192 citing papers, 2.4% of this breakdownHong Kong: 172 citing papers, 2.1% of this breakdownAustralia: 165 citing papers, 2% of this breakdownIndia: 155 citing papers, 1.9% of this breakdown
0%28.9%Other 24.2%

Fields

  • Medicine67.9%
  • Biochemistry, Genetics and Molecular Biology19.7%
  • Immunology and Microbiology8.8%
  • Agricultural and Biological Sciences0.6%
  • Chemistry0.4%
  • Neuroscience0.4%
  • Other2.2%

Topics

  • Viral-associated cancers and disorders12.6%
  • Lymphoma Diagnosis and Treatment6.1%
  • Immune Cell Function and Interaction4%
  • Cytomegalovirus and herpesvirus research3.4%
  • Cervical Cancer and HPV Research2.9%
  • Parvovirus B19 Infection Studies2.6%
  • Other68.4%

Coauthors

All papers

Open in search
  1. Epstein–Barr virus: more than 50 years old and still providing surprises

    Authors: , , - Nature reviews. Cancer 2016 cited by 861

  2. Epstein–Barr virus: 40 years on

    Authors: , - Nature reviews. Cancer 2004 cited by 2,209

  3. Single-cell transcriptomic analysis defines the interplay between tumor cells, viral infection, and the microenvironment in nasopharyngeal carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell Research 2020 cited by 246

  4. The natural history of cervical HPV infection: unresolved issues

    Authors: , , - Nature reviews. Cancer 2006 cited by 1,045

  5. The Role of EBV-Encoded LMP1 in the NPC Tumor Microenvironment: From Function to Therapy

    Authors: , , , , - Frontiers in Oncology 2021 cited by 105

  6. An etiological role for the Epstein-Barr virus in the pathogenesis of classical Hodgkin lymphoma

    Authors: , - Blood 2019 cited by 144

  7. Whole-genome profiling of nasopharyngeal carcinoma reveals viral-host co-operation in inflammatory NF-κB activation and immune escape

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Trevor J. Pugh, Kwok Wai Lo - Nature Communications 2021 cited by 127

  8. Epstein-Barr virus and nasopharyngeal carcinoma

    Authors: , - Chinese Journal of Cancer 2014 cited by 251

  9. Long COVID risk - a signal to address sex hormones and women's health

    Authors: , , , , , - The Lancet Regional Health - Europe 2021 cited by 95

  10. The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC)

    Authors: , , - Seminars in Cancer Biology 2012 cited by 358

  11. Activation of sterol regulatory element‐binding protein 1 (SREBP1)‐mediated lipogenesis by the Epstein–Barr virus‐encoded latent membrane protein 1 (LMP1) promotes cell proliferation and progression of nasopharyngeal carcinoma

    Authors: , , , , , , , , - The Journal of Pathology 2018 cited by 102

  12. Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-κB pathway in carcinoma cells by inhibiting IKK phosphorylation

    Authors: , , , , , , , , , , - Molecular Cancer 2010 cited by 350

  13. A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma†

    Authors: , , , , , , , , , - Hepatology 2008 cited by 281

  14. Genome Diversity of Epstein-Barr Virus from Multiple Tumor Types and Normal Infection

    Authors: , , , , , , , , , , , , , , - Journal of Virology 2015 cited by 271

  15. Advances in pathogenesis and precision medicine for nasopharyngeal carcinoma

    Authors: , , , , , , , - MedComm 2021 cited by 55

  16. Cancer drug sensitivity prediction from routine histology images

    Authors: , , , , , , - npj Precision Oncology 2024 cited by 17

  17. Activation of the FGFR1 signalling pathway by the Epstein–Barr virus‐encoded LMP1 promotes aerobic glycolysis and transformation of human nasopharyngeal epithelial cells

    Authors: , , , , , - The Journal of Pathology 2015 cited by 130

  18. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study

    Authors: , , , , , , , , - The Lancet 2001 cited by 827

  19. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes

    Authors: , , , , , , - Journal of Virology 1990 cited by 498

  20. Epstein–Barr virus-encoded EBNA1 modulates the AP-1 transcription factor pathway in nasopharyngeal carcinoma cells and enhances angiogenesis in vitro

    Authors: , , , , , , , , - Journal of General Virology 2008 cited by 123

  21. Expression of the Epstein-Barr Virus-Encoded Epstein-Barr Virus Nuclear Antigen 1 in Hodgkin's Lymphoma Cells Mediates Up-Regulation of CCL20 and the Migration of Regulatory T Cells

    Authors: , , , , , , , , , , , , , , , , , , , , , - American Journal Of Pathology 2008 cited by 198

  22. NITROREDUCTASE: A PRODRUG‐ACTIVATING ENZYME FOR CANCER GENE THERAPY

    Authors: , , , , , , , , , , , , , , - Clinical and Experimental Pharmacology and Physiology 2004 cited by 125

  23. Cross-linking breast tumor transcriptomic states and tissue histology

    Authors: , , , , , , , , - Cell Reports Medicine 2023 cited by 12

  24. Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) Activates the Phosphatidylinositol 3-Kinase/Akt Pathway to Promote Cell Survival and Induce Actin Filament Remodeling

    Authors: , , , - Journal of Biological Chemistry 2003 cited by 291